Aimfinity Investment Corp I Enters Into SPAC Merger Agreement With Taiwanese Smart Medical Device Developer Docter Inc
Aimfinity Investment Corp I Enters Into SPAC Merger Agreement With Taiwanese Smart Medical Device Developer Docter Inc
Aimfinity Investment Corp. I ("Aimfinity") (NASDAQ:AIMAU), a Cayman Islands incorporated special purpose acquisition company listed on the Nasdaq Global Market, and Docter Inc. ("Docter"), a Taiwanese non-invasive blood glucose watch developer, today announced that they have entered a definitive merger agreement (the "Merger Agreement") pursuant to which a newly established subsidiary of Aimfinity will become a publicly listed company combining Aimfinity and Docter (the "Combined Company") upon the closing of the transaction contemplated therein (the "Proposed Transaction"). Upon closing, the Combined Company expects to list its ordinary shares on Nasdaq.
在纳斯达克全球市场上市的开曼群岛注册特殊目的收购公司Aimfinity Investment Corp.I(“Ainfinity”)(纳斯达克股票代码：AIMAU)和台湾非侵入性血糖手表开发商Docter Inc.(“Docter”)今天宣布，双方已达成最终合并协议(“合并协议”)，根据该协议，Aimfinity的一家新成立的子公司将于其内拟进行的交易(“建议交易”)完成后成为一家由Aimfinity和Docter合并的上市公司(“合并公司”)。完成交易后，合并后的公司预计将其普通股在纳斯达克上市。